Company Profile

Profile last edited on: 8/20/07      CAGE: 3WLZ2      UEI: Z6GMCNT6AJK9

Business Identifier: Quality controls for clinical diagnostic and blood testing laboratories
Year Founded
First Award
Latest Award
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

6058 Egret Court
Benicia, CA 94510
   (707) 746-8888
Location: Single
Congr. District: 05
County: Solano

Public Profile

AcroMetrix is a privately held company specializing in products and services that support the introduction of leading-edge technologies to the medical industry. Combining scientific support, products, and services with Internet accessibility further expands the company’s innovative approach. The company provides quality control products, services and systems to forward-looking companies and institutions engaged in establishing innovative technologies for pharmaceuticals, diagnostics, blood products and related fields. With facilities in CA and Alkmaar, The Netherlands. The Company conducts all critical nucleic acid and serological testing in its own laboratories. This ensures that all of AcroMetrix’s standards, panels and controls meet the highest standards of quality, accuracy and reproducibility. . Using the most advanced project management processes, the firm rapidly transform projects into highly valued products and services for our customers.. AcroMetrix develops and manufactures well-defined standards, external run controls and proficiency and evaluation panels that accelerate the acceptance of a new technology to the marketplace. Custom QC panels and assay controls can be developed to meet the specific needs of diagnostics manufacturers, clinical laboratories, blood centers and other end users. AcroMetrix offers many molecular, serological, and genomic products including a diverse array of nucleic acid panels, controls and standards to meet the needs of virtually any independent verification situation. IN January 2006, the firm received 510(k) clearance from the U.S. Food and Drug Administration for the VeriSure® Pro West Nile Virus (WNV) External Quality Controls. These controls are for use with Chiron’s Procleix® WNV assay that was approved in December 2005 by the FDA for the testing of WNV using nucleic acid amplification. The clearance from the FDA allows these controls to be the first WNV control to be marketed and sold in the United States for “In vitro diagnostic use” in blood

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2001 1 NIH $98,542
Project Title: Molecular Standards for Hepatitis B and C Genotyping

Key People / Management

  Michael J Eck -- President

  Paul D Neuwald

Company News

There are no news available.